Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (81-90 of 307) with videos related to

Pageof 31
Sort By:
Breast Cancer Research and Treatment|August 15, 2019
Allelic modification of breast cancer risk in women with an NBN mutationBogna Rusak, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Biomedicines|November 27, 2021
Blood Copper Levels and the Occurrence of Colorectal Cancer in PolandPiotr Baszuk, Wojciech Marciniak, Róża Derkacz, et al.
Cancers|May 31, 2019
<i>BARD1</i> is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent MutationMalwina Suszynska, Wojciech Kluzniak, Dominika Wokolorczyk, et al.
Hereditary Cancer in Clinical Practice|March 22, 2022
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumorAlicja Ogrodniczak, Janusz Menkiszak, Jacek Gronwald, et al.
Nutrients|April 13, 2024
Serum Levels of Copper and Zinc and Survival in Breast Cancer PatientsMarek Szwiec, Wojciech Marciniak, Róża Derkacz, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
Breast Cancer Research and Treatment|October 16, 2015
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?John Semple, Kelly A Metcalfe, Jan Lubinski, et al.
International Journal of Cancer|December 9, 2014
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
JCO Precision Oncology|April 20, 2022
Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2Wojciech Kluźniak, Agata Szymiczek, Amelie Rodrigue, et al.
Cancers|November 13, 2025
Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer DiagnosisElżbieta Złowocka-Perłowska, Piotr Baszuk, Adam Kiljańczyk, et al.
Pageof 31

Showing results (81-90 of 307) with videos related to

Sort By:
Pageof 31
Breast Cancer Research and Treatment|August 15, 2019
Allelic modification of breast cancer risk in women with an NBN mutationBogna Rusak, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Biomedicines|November 27, 2021
Blood Copper Levels and the Occurrence of Colorectal Cancer in PolandPiotr Baszuk, Wojciech Marciniak, Róża Derkacz, et al.
Cancers|May 31, 2019
<i>BARD1</i> is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent MutationMalwina Suszynska, Wojciech Kluzniak, Dominika Wokolorczyk, et al.
Hereditary Cancer in Clinical Practice|March 22, 2022
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumorAlicja Ogrodniczak, Janusz Menkiszak, Jacek Gronwald, et al.
Nutrients|April 13, 2024
Serum Levels of Copper and Zinc and Survival in Breast Cancer PatientsMarek Szwiec, Wojciech Marciniak, Róża Derkacz, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
Breast Cancer Research and Treatment|October 16, 2015
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?John Semple, Kelly A Metcalfe, Jan Lubinski, et al.
International Journal of Cancer|December 9, 2014
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
JCO Precision Oncology|April 20, 2022
Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2Wojciech Kluźniak, Agata Szymiczek, Amelie Rodrigue, et al.
Cancers|November 13, 2025
Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer DiagnosisElżbieta Złowocka-Perłowska, Piotr Baszuk, Adam Kiljańczyk, et al.
Pageof 31